Showing results (41-50 of 282) with videos related to
Sort By:
Pageof 29
Clinical Therapeutics|October 22, 2024
Cost-effectiveness Analysis of Tumor Treating Fields Therapy Combined With Immune Checkpoint Inhibitor in Metastatic Non-small-cell Lung CancerMengwei Zhang, Ping Yue, Yuanying Feng, et al.Cancer Biology & Therapy|December 19, 2006
PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cellsWei Zou, Xiangguo Liu, Ping Yue, et al.The International Journal of Lower Extremity Wounds|April 11, 2019
Treatment of Diabetic Foot Gangrene Using the STAGE Principle: A Case SeriesChaojun Zhu, Ping Yue, Jiakang Lü, et al.Inflammation|November 1, 2020
Motility and Mechanical Properties of Dendritic Cells Deteriorated by Extracellular AcidosisLu Tong, Ping Yue, Yingying Yang, et al.Cancer Research|April 17, 2002
The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cellsShi-Yong Sun, Ping Yue, Xueyun Chen, et al.Molecular and Cellular Biology|April 29, 2015
mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated DegradationJunghui Koo, Ping Yue, Xingming Deng, et al.The American Journal of Pathology|July 11, 2002
Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune systemDenis G Kay, Ping Yue, Zaher Hanna, et al.Cancer Research|December 6, 2006
Cellular FLICE-inhibitory protein down-regulation contributes to celecoxib-induced apoptosis in human lung cancer cellsXiangguo Liu, Ping Yue, Axel H Schönthal, et al.Cancer Research|June 21, 2011
Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expressionLatha Dhandapani, Ping Yue, Suresh S Ramalingam, et al.Cancer Research|March 15, 2014
Maintaining glycogen synthase kinase-3 activity is critical for mTOR kinase inhibitors to inhibit cancer cell growthJunghui Koo, Ping Yue, Anthony A Gal, et al.Pageof 29